Legal & General Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-54,674
| Closed | -$2.83M | – | 3465 |
|
|
2022
Q3 | $2.83M | Buy |
54,674
+3,680
| +7% | +$152K | ﹤0.01% | 1674 |
|
|
2022
Q2 | $1.26M | Buy |
50,994
+8,111
| +19% | +$179K | ﹤0.01% | 2074 |
|
|
2022
Q1 | $1.07M | Buy |
42,883
+261
| +0.6% | +$7.33K | ﹤0.01% | 2220 |
|
|
2021
Q4 | $1.55M | Sell |
42,622
-88
| -0.2% | -$3.09K | ﹤0.01% | 2121 |
|
|
2021
Q3 | $731K | Buy |
42,710
+9,575
| +29% | +$149K | ﹤0.01% | 2325 |
|
|
2021
Q2 | $443K | Sell |
33,135
-1,078
| -3% | -$26.6K | ﹤0.01% | 2359 |
|
|
2021
Q1 | $1.75M | Sell |
34,213
-362
| -1% | -$21.8K | ﹤0.01% | 2029 |
|
|
2020
Q4 | $2.14M | Sell |
34,575
-61
| -0.2% | -$3.49K | ﹤0.01% | 1864 |
|
|
2020
Q3 | $1.9M | Buy |
34,636
+6,833
| +25% | +$368K | ﹤0.01% | 1781 |
|
|
2020
Q2 | $1.6M | Buy |
27,803
+760
| +3% | +$41.4K | ﹤0.01% | 1820 |
|
|
2020
Q1 | $1.09M | Buy |
27,043
+17,082
| +171% | +$725K | ﹤0.01% | 1825 |
|
|
2019
Q4 | $394K | Buy |
9,961
+1,603
| +19% | +$28.1K | ﹤0.01% | 2266 |
|
|
2019
Q3 | $57K | Hold |
8,358
| – | – | ﹤0.01% | 2696 |
|
|
2019
Q2 | $78K | Buy |
8,358
+3,175
| +61% | +$36.8K | ﹤0.01% | 2618 |
|
|
2019
Q1 | $72K | Buy |
5,183
+1,568
| +43% | +$17.9K | ﹤0.01% | 2605 |
|
|
2018
Q4 | $39K | Buy |
3,615
+594
| +20% | +$6.26K | ﹤0.01% | 2788 |
|
|
2018
Q3 | $38K | Hold |
3,021
| – | – | ﹤0.01% | 2913 |
|
|
2018
Q2 | $40K | Sell |
3,021
-1,562
| -34% | -$18.7K | ﹤0.01% | 2868 |
|
|
2018
Q1 | $62K | Sell |
4,583
-530
| -10% | -$5.47K | ﹤0.01% | 2651 |
|
|
2017
Q4 | $30K | Hold |
5,113
| – | – | ﹤0.01% | 3065 |
|
|
2017
Q3 | $38K | Buy |
5,113
+2,089
| +69% | +$17.4K | ﹤0.01% | 2999 |
|
|
2017
Q2 | $28K | Hold |
3,024
| – | – | ﹤0.01% | 3067 |
|
|
2017
Q1 | $22K | Sell |
3,024
-992
| -25% | -$7.14K | ﹤0.01% | 3059 |
|
|
2016
Q4 | $30K | Buy |
+4,016
| New | +$28.9K | ﹤0.01% | 3031 |
|
Other funds holding CCXI
Legal & General Group's CCXI Position: Q4 2022 in Review
Legal & General Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 54,674 shares — an estimated $2.83M sold.
Legal & General Group first reported a position in CCXI in Q4 2016 and held it in 24 quarters. The position peaked at $2.83M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Legal & General Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Legal & General Group sold 54,674 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.83M.
- Legal & General Group first reported a position in ChemoCentryx, Inc. in Q4 2016 and held it in 24 quarters.
- Legal & General Group's ChemoCentryx, Inc. position peaked at $2.83M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Legal & General Group's 13F filing for Q4 2022, filed 14 Feb 2023.